{
    "2021-09-07": [
        [
            {
                "time": "2023-11-20",
                "original_text": "北向资金追平年内最长净买入记录累计加仓超550亿，美的集团净买入超11亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "美的集团"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "家电"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-20",
                "original_text": "累计投入约4.85亿恒瑞医药两款注射液获批临床试验",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "注射液",
                        "临床试验"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-20",
                "original_text": "恒瑞医药两款注射液传捷报",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "注射液",
                        "捷报"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-09-06",
                "original_text": "A股融资融券日报：两融余额增加117.03亿元",
                "features": {
                    "keywords": [
                        "两融余额",
                        "A股",
                        "融资融券"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-20",
                "original_text": "14股获券商买入评级，比亚迪目标涨幅达29.94%",
                "features": {
                    "keywords": [
                        "券商评级",
                        "比亚迪",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "汽车"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-20",
                "original_text": "医药生物行业：重视头部创新药企业布局良机",
                "features": {
                    "keywords": [
                        "医药生物",
                        "创新药",
                        "布局良机"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-20",
                "original_text": "医药子板块全线走高，核心资产现企稳迹象",
                "features": {
                    "keywords": [
                        "医药子板块",
                        "核心资产",
                        "企稳"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}